📣 VC round data is live. Check it out!

Kenvue Valuation Multiples

Discover revenue and EBITDA valuation multiples for Kenvue and similar public comparables like Henkel, Estee Lauder, Reckitt, Haleon and more.

Kenvue Overview

About Kenvue

Kenvue is the world’s largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson’s consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women’s health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson’s, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.


Founded

2022

HQ

United States

Employees

22.0K

Website

kenvue.com

Financials (LTM)

Revenue: $15B
EBITDA: $4B

EV

$41B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Kenvue Financials

Kenvue reported last 12-month revenue of $15B and EBITDA of $4B.

In the same LTM period, Kenvue generated $9B in gross profit, $4B in EBITDA, and $2B in net income.

Revenue (LTM)


Kenvue P&L

In the most recent fiscal year, Kenvue reported revenue of $15B and EBITDA of $3B.

Kenvue is profitable as of last fiscal year, with gross margin of 58%, EBITDA margin of 23%, and net margin of 14%.

See analyst estimates for Kenvue
LTMLast FY202320242025202620272028
Revenue$15B$15B$15B$15B$15B
Gross Profit$9B$9B$9B$9B$9B
Gross Margin60%58%56%58%58%
EBITDA$4B$3B$3B$2B$3B
EBITDA Margin23%23%21%16%20%
EBIT Margin21%21%16%17%18%
Net Profit$2B$2B$2B$1B$1B
Net Margin14%14%11%7%10%
Net Debt—$7B———

Financial data powered by Morningstar, Inc.

Kenvue Stock Performance

Kenvue has current market cap of $33B, and enterprise value of $41B.

Market Cap Evolution


Kenvue's stock price is $17.15.

Kenvue share price decreased by 2.2% in the last 30 days, and by 28.2% in the last year.

Kenvue has an EPS (earnings per share) of $1.08.

See more trading valuation data for Kenvue
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$41B$33B-0.2%-2.2%-10.3%-28.2%$1.08

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Kenvue Valuation Multiples

Kenvue trades at 2.7x EV/Revenue multiple, and 11.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Kenvue

EV / Revenue (LTM)


Kenvue Financial Valuation Multiples

As of May 20, 2026, Kenvue has market cap of $33B and EV of $41B.

Kenvue has a P/E ratio of 15.3x.

LTMLast FY202320242025202620272028
EV/Revenue2.7x2.7x2.6x2.6x2.7x
EV/EBITDA11.4x11.8x12.8x16.5x13.6x
EV/EBIT12.4x12.8x16.4x15.4x15.0x
EV/Gross Profit4.4x4.6x4.7x4.5x4.6x
P/E15.3x15.9x19.8x32.0x22.4x
EV/FCF19.8x20.2x15.1x30.5x23.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Kenvue Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Kenvue Margins & Growth Rates

Kenvue grew revenue by 3% and EBITDA by 11% in the last fiscal year.

In the most recent fiscal year, Kenvue reported gross margin of 58%, EBITDA margin of 23%, and net margin of 14%.

See estimated margins and future growth rates for Kenvue

Kenvue Margins

Last FY202420252026202720282029
Gross Margin58%58%58%61%
EBITDA Margin23%16%20%24%
EBIT Margin21%17%18%22%
Net Margin14%7%10%15%
FCF Margin13%9%11%13%

Kenvue Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth3%0%(2%)3%
Gross Profit Growth8%4%(2%)8%
EBITDA Growth11%(22%)21%28%
EBIT Growth10%6%3%28%
Net Profit Growth10%(38%)43%56%
FCF Growth5%(51%)29%22%

Data powered by FactSet, Inc. and Morningstar, Inc.

Kenvue Operational KPIs

Kenvue's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.3M for the same period.

Kenvue's Rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Kenvue's Rule of X is 33% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Kenvue
LTMLast FY202320242025202620272028
Rule of 4026%28%———
Bessemer Rule of X31%33%———
Revenue per Employee—$0.7M———
Opex per Employee—$0.3M———
Opex to Revenue—40%40%41%40%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Kenvue Competitors

Kenvue competitors include Henkel, Estee Lauder, Reckitt, Haleon, Church & Dwight, Bayer, Ulta Beauty, Galderma, Essity and Beiersdorf.

Most Kenvue public comparables operate across Health & Beauty.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Henkel1.3x1.3x7.1x7.1x
Estee Lauder2.4x2.3x17.1x14.0x
Reckitt2.5x2.7x7.6x9.1x
Haleon3.3x3.3x12.9x12.6x
Church & Dwight3.9x3.9x17.2x17.0x
Bayer1.4x1.4x6.8x6.9x
Ulta Beauty1.8x1.8x12.3x12.1x
Galderma9.2x8.6x39.9x35.3x

This data is available for Pro users. Sign up to see all Kenvue competitors and their valuation data.

Start Free Trial

Kenvue Funding History

Before going public, Kenvue raised $4B in total equity funding, across 1 round.


Kenvue Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
May-24Secondary - publicGoldman Sachs; J.P. Morgan Securities$4B—Kenvue Inc. (NYSE: KVUE), a consumer health company spun off from Johnson & Johnson, completed a secondary underwritten public offering of 182,329,550 shares at $20.00 per share, priced around May 14, 2024, and expected to close on May 17, 2024. Johnson & Johnson exchanged these shares for its own indebtedness held by Goldman Sachs & Co. LLC and J.P. Morgan, after which the selling shareholders offered the shares to underwriters. Goldman Sachs & Co. LLC, J.P. Morgan, and BofA Securities served as joint lead book-running managers. Kenvue did not sell shares or receive proceeds from the offering.

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Kenvue

When was Kenvue founded?Kenvue was founded in 2022.
Where is Kenvue headquartered?Kenvue is headquartered in United States.
How many employees does Kenvue have?As of today, Kenvue has over 22K employees.
Who is the CEO of Kenvue?Kenvue's CEO is Kirk L. Perry.
Is Kenvue publicly listed?Yes, Kenvue is a public company listed on NYSE.
What is the stock symbol of Kenvue?Kenvue trades under KVUE ticker.
When did Kenvue go public?Kenvue went public in 2023.
Who are competitors of Kenvue?Kenvue main competitors include Henkel, Estee Lauder, Reckitt, Haleon, Church & Dwight, Bayer, Ulta Beauty, Galderma, Essity, Beiersdorf.
What is the current market cap of Kenvue?Kenvue's current market cap is $33B.
What is the current revenue of Kenvue?Kenvue's last 12 months revenue is $15B.
What is the current revenue growth of Kenvue?Kenvue revenue growth (NTM/LTM) is 3%.
What is the current EV/Revenue multiple of Kenvue?Current revenue multiple of Kenvue is 2.7x.
Is Kenvue profitable?Yes, Kenvue is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Kenvue?Kenvue's last 12 months EBITDA is $4B.
What is Kenvue's EBITDA margin?Kenvue's last 12 months EBITDA margin is 23%.
What is the current EV/EBITDA multiple of Kenvue?Current EBITDA multiple of Kenvue is 11.4x.
What is the current FCF of Kenvue?Kenvue's last 12 months FCF is $2B.
What is Kenvue's FCF margin?Kenvue's last 12 months FCF margin is 13%.
What is the current EV/FCF multiple of Kenvue?Current FCF multiple of Kenvue is 19.8x.
How many companies Kenvue has acquired to date?Kenvue hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Kenvue has invested to date?Kenvue hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Kenvue

Lists including Kenvue

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial